LATEST NEWS
August 30, 2019 / NEWS
US FDA approves Mylan generic of Lilly lung cancer drug Alimta
August 29, 2019 / NEWS
Anifrolumab Phase III trial meets primary endpoint in systemic lupus erythematosus
August 29, 2019 / NEWS
European Commission approves Roche’s Tecentriq in combination with Abraxane for people with PD-L1-positive, metastatic triple-negative breast cancer
August 27, 2019 / NEWS
FDA approves new add-on drug to treat off episodes in adults with Parkinson’s disease
April 23, 2019 / NEWS
Torrent Pharmaceuticals Expands Voluntary Recall Of Losartan Tablets
April 23, 2019 / NEWS
FDA Approves First Generic Nasal Spray To Treat Opioid Overdose
April 18, 2019 / NEWS
FDA Accepts NDA For ALS Treatment Riluzole Oral Film.
April 17, 2019 / NEWS
Olanzapine-Samidorphan Combination Show Safety, Efficacy In Patients With Schizophrenia
April 17, 2019 / NEWS
FDA Approves Prescription Weight Loss Drug
April 15, 2019 / NEWS
First two-drug pill approved for new HIV treatment starters
April 15, 2019 / NEWS
First Targeted Therapy for Metastatic Bladder Cancer Gets FDA Approval
April 12, 2019 / NEWS
FDA Approves Expanded Keytruda Monotherapy Label for First-Line NSCLC
April 10, 2019 / NEWS
FDA approves new osteoporosis drug for postmenopausal women
April 09, 2019 / NEWS
FDA Expands Use of Breast Cancer Drug to Include Men
December 28, 2018 / NEWS
TFDA announcement: the due date of application for amendment replied document is changed to 14 days and implemented from July 1, 2019
November 13, 2018 / NEWS
TFDA entrust 35 intitutions to review the informed consent form that used in clinical trials from 06Nov2018 to 31Dec2020.
August 21, 2018 / NEWS
TFDA-The monitoring management and processing principle for custom clearance of Lab kit imports in the drug clinical trials
August 20, 2018 / NEWS
Implementation of the Enhanced Domestic Bioequivalence Study Inspection since January 1, 2018 by TFDA
ABOUT US
Do-Intelligent Consulting Inc. is a professional Site Management Organization (SMO) that has established in June 2018. Chairman
Our President and Vice President possess over 15 years of experience in the clinical trial field and the Professional team members also possess a lot of experience in Phase I-IV and BA/BE studies over the years.
We can provide the full service of clinical trials to the study sites, biotechnology, pharmaceutical and contract research organization (CRO) companies.
SERVICE